These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Brynedal B; Khademi M; Wallström E; Hillert J; Olsson T; Duvefelt K Neurobiol Dis; 2010 Mar; 37(3):613-21. PubMed ID: 19944761 [TBL] [Abstract][Full Text] [Related]
6. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Achiron A; Feldman A; Mandel M; Gurevich M Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543 [TBL] [Abstract][Full Text] [Related]
12. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819 [TBL] [Abstract][Full Text] [Related]
13. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681 [TBL] [Abstract][Full Text] [Related]
14. The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors. Gurevich M; Achiron A J Neuroimmunol; 2012 Nov; 252(1-2):83-8. PubMed ID: 22921736 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Martinelli-Boneschi F; Fenoglio C; Brambilla P; Sorosina M; Giacalone G; Esposito F; Serpente M; Cantoni C; Ridolfi E; Rodegher M; Moiola L; Colombo B; De Riz M; Martinelli V; Scarpini E; Comi G; Galimberti D Neurosci Lett; 2012 Feb; 508(1):4-8. PubMed ID: 22108567 [TBL] [Abstract][Full Text] [Related]
17. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels. Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542 [TBL] [Abstract][Full Text] [Related]
18. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis. Achiron A; Gurevich M; Snir Y; Segal E; Mandel M Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294 [TBL] [Abstract][Full Text] [Related]
19. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Soelberg Sorensen P Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269 [TBL] [Abstract][Full Text] [Related]
20. Aberrant transcriptional regulatory network in T cells of multiple sclerosis. Satoh J; Illes Z; Peterfalvi A; Tabunoki H; Rozsa C; Yamamura T Neurosci Lett; 2007 Jul; 422(1):30-3. PubMed ID: 17629622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]